Dr. Hope L Johnson is currently the Director of
Measurement, Evaluation and Learning of Gavi, the Vaccine Alliance, where she
is responsible for overseeing the monitoring and evaluation of Gavi’s strategy,
programs, policies and priority initiatives; and management of Gavi investments
in immunization data strengthening and research. She is an infectious disease
epidemiologist with 25 years’ experience in public health, including 18 years
in vaccines and immunisation from country to global levels. Before joining Gavi
in 2012, she worked for five years in support of its mission while at the
International Vaccine Access Center (IVAC) on the Gavi-funded Pneumococcal
Accelerated Development and Introduction Plan (PneumoADIP). She has served as a
faculty member and instructor at the Johns Hopkins University Bloomberg School
of Public Health, of which she is a graduate with PhD and Master of Public
Health degrees in Global Disease Epidemiology and Control, and specialization
in vaccine sciences and policy. While working in academia for ten years, she
conducted surveillance and investigational drug and device clinical trials; and
she published systematic reviews, evidence syntheses and disease burden and
economic modeling studies informing policy and strategy development. Prior to
this, Dr. Johnson held several roles as a researcher, working to strengthen
countries’ local epidemiology and national health information systems,
including with the Pan American Health Organization (PAHO).
Dr. Hope L Johnson is currently the Director of
Measurement, Evaluation and Learning of Gavi, the Vaccine Alliance, where she
is responsible for overseeing the monitoring and evaluation of Gavi’s strategy,
programs, policies and priority initiatives; and management of Gavi investments
in immunization data strengthening and research. She is an infectious disease
epidemiologist with 25 years’ experience in public health, including 18 years
in vaccines and immunisation from country to global levels. Before joining Gavi
in 2012, she worked for five years in support of its mission while at the
International Vaccine Access Center (IVAC) on the Gavi-funded Pneumococcal
Accelerated Development and Introduction Plan (PneumoADIP). She has served as a
faculty member and instructor at the Johns Hopkins University Bloomberg School
of Public Health, of which she is a graduate with PhD and Master of Public
Health degrees in Global Disease Epidemiology and Control, and specialization
in vaccine sciences and policy. While working in academia for ten years, she
conducted surveillance and investigational drug and device clinical trials; and
she published systematic reviews, evidence syntheses and disease burden and
economic modeling studies informing policy and strategy development. Prior to
this, Dr. Johnson held several roles as a researcher, working to strengthen
countries’ local epidemiology and national health information systems,
including with the Pan American Health Organization (PAHO).